Search

everythinglearnresearchcommunity

for

Search:↓

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

Drugs like PDEI may help hair disorders like AGA.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

NGF-modified hair follicle stem cells may help treat Alzheimer's by improving brain function and reducing harmful proteins.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

Ayurvedic treatment successfully regrew hair in a 19-year-old with alopecia areata in 2 months.

A tailored treatment improved a Pomeranian dog's skin and hair issues caused by a vaccine.

Antibody treatments show promise for hair loss but need more research.

Understanding and treating alopecia areata improves patient care.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Stress-related hair loss was reversed with a special medication.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

PGD2 stops hair growth and is higher in bald men with AGA.

Midazolam impairs learning and memory by increasing neurosteroids through specific receptor activation.

Cyclosporine A may help treat hair loss by blocking a protein that inhibits hair growth.

Zinc supplements increased zinc levels in some hair loss patients but didn't significantly improve hair growth.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Finasteride reduces melanin production, possibly treating hyperpigmentation and melanoma, but needs more safety research.

The Drug Ontology was updated to better classify drugs for hypertension, malaria, and opioid abuse, and to allow for more accurate research queries.

Topical cetirizine 1% promotes hair growth in male androgenetic alopecia patients.